Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 4038  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Low vs standard dose of recombinant tissue plasminogen activator in treating East Asian patients with acute ischemic stroke

Dharmasaroja Pornpatr A, Pattaraarchachai Junya

Year : 2011| Volume: 59| Issue : 2 | Page no: 180-184

   This article has been cited by
 
1 Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Ji-Wei Cheng,Xiao-Jing Zhang,Li-Shan Cheng,Guo-Yi Li,Li-Jun Zhang,Kang-Xiang Ji,Qing Zhao,Yu Bai
Journal of Stroke and Cerebrovascular Diseases. 2018; 27(2): 381
[Pubmed]  [Google Scholar] [DOI]
2 The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
Qiang Dong,Yi Dong,Liping Liu,Anding Xu,Yusheng Zhang,Huaguang Zheng,Yongjun Wang
Stroke and Vascular Neurology. 2017; 2(3): 147
[Pubmed]  [Google Scholar] [DOI]
3 Consensus Statement on the Use of Intravenous Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke by the Chinese Stroke Therapy Expert Panel
An-Ding Xu,Yong-Jun Wang,David Z Wang
CNS Neuroscience & Therapeutics. 2013; 19(8): 543
[Pubmed]  [Google Scholar] [DOI]

 

Online since 20th March '04
Published by Wolters Kluwer - Medknow